United Kingdom· GB-APID-40348011000001102
COVID-19 Vaccine Covishield (ChAdOx1 S [recombinant]) 5x10,000,000,000 viral particles/0.5ml dose solution for injection multidose vials
A medicinal product containing covid-19 vaccine, registered in United Kingdom by Serum Institute of India.
Checked against NHS dm+d (United Kingdom) on
Informational only — not a medical device.
The record
At a glance
NHS dm+d (United Kingdom)- Active substance
- COVID-19 vaccine
- Manufacturer
- Serum Institute of India
- Country
- United Kingdom (GB)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- NHS dm+d (United Kingdom)
- Last checked
- September 13, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of NHS dm+d (United Kingdom). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/fa9babea-4a36-426b-a83b-f11b9533c790 GET /v1/drugs/fa9babea-4a36-426b-a83b-f11b9533c790?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"apid": "40348011000001102",
"desc": "COVID-19 Vaccine Covishield (ChAdOx1 S [recombinant]) 5x10,000,000,000 viral particles/0.5ml dose solution for injection multidose vials (Serum Institute of India)",
"form": "Solution for injection",
"vpid": "40366311000001107",
"source": "dmd",
"vtm_id": "39330711000001103",
"strength": null,
"substance": "COVID-19 vaccine",
"ingredient": null,
"supplier_code": "40367111000001108"
}See everything about covid-19 vaccine.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.